Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$4.35 - $15.85 $570,572 - $2.08 Million
-131,166 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$4.55 - $6.41 $5,551 - $7,820
-1,220 Reduced 0.92%
131,166 $634,000
Q4 2021

Feb 03, 2022

BUY
$5.89 - $9.73 $206,267 - $340,744
35,020 Added 35.97%
132,386 $780,000
Q3 2021

Nov 08, 2021

SELL
$6.78 - $9.89 $190,741 - $278,235
-28,133 Reduced 22.42%
97,366 $831,000
Q2 2021

Aug 05, 2021

BUY
$7.24 - $11.2 $908,612 - $1.41 Million
125,499 New
125,499 $1.01 Million

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.